Efficacy And Safety Of Fingolimod 0.5 Mg Every-Other Day In Multiple Sclerosis Patients Who Presented Severe Adverse Events When On Conventional Fingolimod Treatment
MULTIPLE SCLEROSIS JOURNAL（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL（2016）